Recent warnings to a contract manufacturer and two of its customers are reminders that the US Food and Drug Administration, since subjecting homeopathics to the same regulatory requirements as other types of drugs, is prioritizing products indicated for children in its inspections.
The agency on 15 August published warning letters noting good manufacturing practice regulations violations and sent earlier in the month to contract manufacturer Denison Pharmaceuticals LLC in Lincoln, RI, and two of its customers,
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?